Form 4: Lovesac Director Walter McLallen Reports Stock Vesting
SEC Form 4 Filing
Walter McLallen, a director at Lovesac Co, reports the vesting of restricted stock units resulting in the acquisition of 6,702 shares of common stock on April 4, 2025.
Summary
- On April 4, 2025, Walter McLallen, a director of Lovesac Co, reported a transaction involving the vesting of restricted stock units (RSUs).
- This vesting resulted in the acquisition of 6,702 shares of Lovesac's common stock.
- Following the transaction, McLallen directly owns 31,242 shares of Lovesac common stock.
- The RSUs were granted on April 4, 2024, and each RSU represents the right to receive one share of Lovesac common stock upon vesting.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock vesting, which is part of the director's compensation package.
Positives
- The vesting of RSUs indicates that McLallen has met certain conditions, likely related to his service as a director.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard vesting schedule for director compensation.
Stakeholder Impact
- The vesting of RSUs has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/04/2024 | Date of grant for the restricted stock units (RSUs). |
| 04/04/2025 | Date of transaction: vesting of 6,702 restricted stock units and acquisition of common stock. |
| 04/07/2025 | Date of Form 4 filing. |
Keywords
Lovesac, Director, McLallen, Stock Vesting, RSU, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.